NASDAQ: RVMD
Revolution Medicines, Inc.
Healthcare · Biotechnology
After hours: $163.90(+0.56%) · as of 7:57 PM ET
Market Cap
$34.65B
52w High
$166.50
52w Low
$34.00
P/E
-23.54
Volume
4.01M
Outstanding Shares
212.60M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 308.19% over the last year. Free cash flow declined 78.11% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
A decisive shift in revenue or cash flow over the next period would be the clearest signal to resolve the ambiguity.
Company profile
Revolution Medicines, Inc. is a precision oncology firm operating in the clinical development stage, dedicated to creating innovative treatments that target novel pathways crucial for RAS-driven cancers.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
21
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 5, 2026
Q3 FY26 · EPS est -$1.96 · Revenue est $18.06M
View